Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments

Summary by STAT
The lawsuit is a reminder of the profits at stake for treating prostate cancer, a market forecast to generate $28 billion in U.S. sales by 2033.

2 Articles

STATSTAT
Center

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments

The lawsuit is a reminder of the profits at stake for treating prostate cancer, a market forecast to generate $28 billion in U.S. sales by 2033.

·Boston, United States
Read Full Article
larepublica.colarepublica.co

Bayer Accuses J&j of Misleading Advertising for Prostate Cancer Medicine

Bayer argues that J&J's advertisements falsely claimed that Erleada users showed a "51 % reduction in the risk of death" compared to Cloudqa patients.

·Bogotá, Colombia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Monday, February 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

Advertising icon

Advertising

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal